136 related articles for article (PubMed ID: 2264389)
81. [The effect of cytostatic and immunomodulator therapy on the morphology of the tumor and lymphoid organs and on the count of large granular lymphocytes in the blood of mice with Lewis carcinoma].
Potapov IuI; Khaleev DV; Krutova TV; Pashkova VS
Izv Akad Nauk Ser Biol; 1993; (1):155-9. PubMed ID: 8471967
[TBL] [Abstract][Full Text] [Related]
82. Residual marrow damage from cytotoxic drugs.
Morley A
Aust N Z J Med; 1980 Oct; 10(5):569-71. PubMed ID: 6937171
[No Abstract] [Full Text] [Related]
83. [Comparative analysis of the effect of phentyrin and azathioprine on hemopoietic tissue].
Voĭlokova PIa
Probl Gematol Pereliv Krovi; 1977 Jan; 22(1):41-5. PubMed ID: 834739
[No Abstract] [Full Text] [Related]
84. Role of serotonin in the regulation of granulocytopoiesis during cytostatic-induced myelosuppressions.
Skurikhin EG; Pershina OV; Minakova MY; Dygai AM; Gol'dberg ED
Bull Exp Biol Med; 2007 May; 143(5):569-74. PubMed ID: 18239769
[TBL] [Abstract][Full Text] [Related]
85. Acute and chronic anaesthetic actions on leukocytes.
Bruce DL
Can Anaesth Soc J; 1973 Jan; 20(1):55-63. PubMed ID: 4571973
[No Abstract] [Full Text] [Related]
86. [Toxic lesions caused by cytostatic drugs].
Gropp C; Havemann K
Internist (Berl); 1980 Dec; 21(12):739-45. PubMed ID: 7009476
[No Abstract] [Full Text] [Related]
87. [Effect of Lacto Flor on immunological and hematopoietic systems in experimental hemolytic anemia].
Askarov TA
Lik Sprava; 2004; (3-4):84-7. PubMed ID: 15318836
[TBL] [Abstract][Full Text] [Related]
88. Protective effect of amino acids and oligopeptides in combination with a cytostatic agent on lymphoid tissue culture.
Chalisova NI; Lesnyak VV; Nozdrachev AD
Dokl Biol Sci; 2009; 424():25-8. PubMed ID: 19341077
[No Abstract] [Full Text] [Related]
89. Hemostimualting properties of preparation containing ultralow doses of antibodies to stem cell factor in cytostatic myelosuppression.
Stavrova LA; Zyuz'kov GN; Simanina EV; Miroshnichenko LA; Udut EV; Khrichkova TY; Skurikhin EG; Pershina OV; Ermakova NN; Firsova TV; Zhdanov VV; Dygai AM; Gol'dberg ED
Bull Exp Biol Med; 2009 Sep; 148(3):556-9. PubMed ID: 20396740
[TBL] [Abstract][Full Text] [Related]
90. [Correction of immune and hematopoietic system disorders in experimental toxic hepatitis with Lacto Flor].
Askarov TA
Lik Sprava; 2004; (5-6):71-3. PubMed ID: 15605828
[TBL] [Abstract][Full Text] [Related]
91. Cytokine-induced changes in the leukon.
Anderson TD
Toxicol Pathol; 1993; 21(2):147-57. PubMed ID: 8210936
[TBL] [Abstract][Full Text] [Related]
92. Bone marrow regeneration under cytotoxic drug regimens: behaviour ranging from homeostasis to unpredictability in a model for hemopoietic differentiation.
Mehr R; Agur Z
Biosystems; 1992; 26(4):231-7. PubMed ID: 1627734
[TBL] [Abstract][Full Text] [Related]
93. [Inhibition of hemopoiesis due to cytostatic therapy and its treatment (author's transl)].
Klener P; Donner L; Smotlachová I
Cas Lek Cesk; 1977 Feb; 116(4):117-9. PubMed ID: 844069
[No Abstract] [Full Text] [Related]
94. [Effect of experimental choriogonin and azathioprine on hematopoietic and lymphoid tissue].
Nikitina VV
Gematol Transfuziol; 1987 Jan; 32(1):46-9. PubMed ID: 3817425
[No Abstract] [Full Text] [Related]
95. Dalayed Effects of Antitumor Drug Paclitaxel on the Hereditary Material and Hemopoietic System of CBA Mice.
Neupokoeva OV; Fedorova EP; Stavrova LA; Voronova OL; Sandrikina LA; Filonova MV; Churin AA
Bull Exp Biol Med; 2020 May; 169(1):43-47. PubMed ID: 32488780
[TBL] [Abstract][Full Text] [Related]
96. Studies on lymphoid tissue damage with a toxic phytohemagglutinin and its subfractions in mice.
Baba M
Bull Chest Dis Res Inst Kyoto Univ; 1976 Mar; 9(1-2):17-28. PubMed ID: 1009247
[No Abstract] [Full Text] [Related]
97. Protective effect of tripeptide in the presence of cyclophosphamide on the growth of cultured lymphoid tissue from rats of different age.
Chalisova NI; Lesnyak VV; Oganezova EV; Rizhak GA
Bull Exp Biol Med; 2008 Jun; 145(6):748-50. PubMed ID: 19110568
[TBL] [Abstract][Full Text] [Related]
98. "Delayed death" phenomenon: a synergistic action of cyclophosphamide and exogenous DNA.
Dolgova EV; Proskurina AS; Nikolin VP; Popova NA; Alyamkina EA; Orishchenko KE; Rogachev VA; Efremov YR; Dubatolova TD; Prokopenko AV; Chernykh ER; Ostanin AA; Taranov OS; Omigov VV; Zagrebelniy SN; Bogachev SS; Shurdov MA
Gene; 2012 Mar; 495(2):134-45. PubMed ID: 22227496
[TBL] [Abstract][Full Text] [Related]
99. Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic function.
Richards SM; Murphy WJ
J Neuroimmunol; 2000 Sep; 109(1):56-62. PubMed ID: 10969182
[TBL] [Abstract][Full Text] [Related]
100. The role of chemotherapy in the treatment of malignant lesions of the lymphoid and hemopoietic tissues.
ABOUL-NASR AL
Acta Unio Int Contra Cancrum; 1959; 15(Suppl 1)():23-69. PubMed ID: 13791516
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
